A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy

Author: Ibsen Stuart   Zahavy Eran   Wrasdilo Wolf   Berns Michael   Chan Michael   Esener Sadik  

Publisher: Springer Publishing Company

ISSN: 0724-8741

Source: Pharmaceutical Research, Vol.27, Iss.9, 2010-09, pp. : 1848-1860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract